Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant MelanomaMark R. Middleton, N. Thatcher, Simone Seiter et al.|Journal of Clinical Oncology|2000Cited by 1.3k
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trialAlexander M.M. Eggermont, Ulrich Keilholz, Stefan Suciu et al.|The Lancet|2008Cited by 642
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsAngela George, Nazneen Rahman, Daniel Riddell et al.|Scientific Reports|2016Cited by 224
Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian CancerFrancisco José Cândido dos Reis, Honglin Song, Ellen L. Goode et al.|Clinical Cancer Research|2014Cited by 160
Axitinib for the Management of Metastatic Renal Cell CarcinomaBernard Escudier, Martin Gore|Drugs in R&D|2011Cited by 147